Concepedia

Author

Riccardo Nevola

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

Nevola Riccardo, R Nevola, R. Nevola, Riccardo NEVOLA, Riccardo Nevola

87

Publications

2.8K

Citations

29

H-Index

49

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"University of MilanFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoOspedale D. CotugnoUniversity of Palermo
RN

About

Riccardo Nevola is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, hepatology, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

591

2

Diabetes

4

4

265

3

Public Health

3

3

166

4

Health Sciences

2

2

165

5

Biochemistry

1

1

63

Riccardo Nevola

×

27

Publications

1.3K

Citations

19

H-Index

YearCitations

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon,

Cardiovascular Diabetology

2021

126

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

Salvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani,

Journal of Hepatology

2018

117

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact

Alfredo Caturano, Carlo Acierno, Riccardo Nevola,

Processes

2021

102

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani,

Atherosclerosis

2020

95

Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients

Luigi Elio Adinolfi, Riccardo Nevola, Barbara Guerrera,

Journal of Gastroenterology and Hepatology

2017

90

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study

Luigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani,

Diabetes Obesity and Metabolism

2020

73

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero,

Cardiovascular Diabetology

2022

72

Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study

Aldo Marrone, Riccardo Nevola, Ausilia Sellitto,

Clinical Infectious Diseases

2022

69

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi,

Exploration of Medicine

2020

63

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study

Luca Rinaldi, Alessandro Perrella, Maria Guarino,

Journal of Translational Medicine

2019

61

Page 1